Boc-L-Glu(Bzl)-OSu

Boc-L-Glu(Bzl)-OSu is a Boc-protected L-glutamic acid derivative bearing a benzyl-protected side-chain carboxyl group and an activated N-hydroxysuccinimide (OSu) ester. This combination makes the molecule a commonly handled peptide-coupling building block for forming amide bonds under conditions compatible with protected amino acid chemistry, while the Boc and benzyl groups provide orthogonal protection during sequential assembly. Researchers use this activated glutamate reagent to introduce a protected glutamic acid residue with controlled functionality into peptide segments and related intermediate syntheses.

1. Peptide Coupling Building Block

Boc-L-Glu(Bzl)-OSu is used as an activated amino acid building block for peptide synthesis workflows that require efficient amide bond formation at the glutamate side-chain position while preserving orthogonal protection. Peptide chemists and custom peptide manufacturing groups select this OSu-activated form to couple glutamate-containing segments with reduced coupling burden compared with less activated carboxylic acid derivatives, supporting reliable assembly of protected peptide intermediates. The Boc group on the alpha-amino functionality and the benzyl ester on the side-chain carboxyl help maintain chemoselectivity during stepwise chain elongation, which is particularly valuable when building longer sequences or preparing glutamate-rich peptide fragments.

2. Protected Glutamate Intermediate Synthesis

Boc-L-Glu(Bzl)-OSu serves as a practical glutamate-based intermediate for preparing protected amide derivatives and peptide fragments used in medicinal chemistry and structure-activity relationship studies. Pharmaceutical intermediate development teams often rely on OSu-activated amino acids to generate amide-linked intermediates under standard peptide-coupling conditions, then carry the protected glutamate functionality forward into downstream transformations. The presence of both Boc and benzyl-protected carboxyl functionality supports isolation and handling of intermediates without premature deprotection, which helps streamline the synthesis of glutamate-containing conjugates and segment precursors used in iterative medicinal chemistry campaigns.

3. Solution-Phase Segment Assembly

Boc-L-Glu(Bzl)-OSu is frequently employed in solution-phase peptide synthesis and segment condensation strategies where activated amino acid derivatives are preferred for controlled coupling between preformed peptide fragments. In laboratories developing protected peptide segments for later purification and final assembly, the OSu ester activation enables straightforward conversion of the glutamate carboxyl into an amide linkage with an appropriate amine partner while maintaining the protective-group pattern required for subsequent deprotection steps. This makes the reagent a useful choice for researchers assembling glutamate-containing sequences that require consistent protection of both the alpha-amino functionality (Boc) and the side-chain carboxyl (benzyl) throughout the coupling and purification steps.

4. Peptide Library and Analog Preparation

Boc-L-Glu(Bzl)-OSu is also used in the preparation of glutamate-containing peptide analogs for library-style synthesis, where multiple amide-linked variants are generated from a common protected glutamate building block. Chemical biology and medicinal chemistry groups preparing focused analog sets benefit from the reproducible coupling behavior of OSu-activated amino acids when generating series of protected peptide intermediates that later undergo uniform deprotection and final processing. The protected glutamate identity delivered by this reagent supports systematic variation at other positions in the peptide while keeping the glutamate side-chain protected in a consistent manner across the analog set.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis